Hormonal treatment of breast tumor
Garcia Giralt, E.; Omodei Zorini, C.
La Clinica Terapeutica 132(4): 217-227
1990
ISSN/ISBN: 0009-9074 PMID: 2140308 Document Number: 362687
Document emailed within 1 workday
Related Documents
Meiss, L.; Djandji, V.; Raute, M.; Kühn, W. 1974: Therapy of breast carcinoma. Surgical, radiologic and hormonal treatment of a patient with breast carcinoma metastases. Clinical course with regard to pre-terminal immunoglobulin and complement changes Fortschritte der Medizin 92(14): 615-616Strnad, P.; Cech, E.; Vachousek, J.; Smejkal, V.; Velek, J. 1995: Hormonal treatment of non-malignant diseases of the breast Casopis Lekaru Ceskych 134(3): 67-72
Rivadeneyra, J. 1977: Progress in the hormonal treatment of advanced cancer of the breast Ginecologia y Obstetricia de Mexico 42(252): 247-249
Siracká, E.; Simko, I.; Siracký, J. 1970: The importance of sex chromatin determination in the hormonal treatment of breast cancer Neoplasma 17(6): 625-629
Telhaug, R.; Fosså, S.D.; Lund, G.; Børmer, O. 1982: Hormonal treatment of breast cancer in men. Experiences with antiestrogen Tamoxifen Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 102(34-36): 1849-1851
Prodi, G.; Lollini, P.L.; Nicoletti, G. 1984: New data on relations between residual hormonal modulability and medical treatment of breast adenocarcinoma Minerva Medica 75(6): 219-221
Loven, D.; Rakowsky, E.; Stein, J.A.; Geier, A.; Lunenfeld, B. 1981: Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients Israel Journal of Medical Sciences 17(9-10): 960-964
Lanfranchi, A. 2014: Normal breast physiology: the reasons hormonal contraceptives and induced abortion increase breast-cancer risk Issues in Law and Medicine 29(1): 135-146
Jamin, C. 2003: Traitement hormonal de la ménopause et risque vasculaire : Le traitement hormonal substitutif : WHI un an après - Hormonal treatment of menopause and vascular risk la Lettre du Gynecologue (283): 27-30
Thomas, C.M.; Wobbes, T.; Bonfrer, J.M.; Peterse, J.L.; Nap, M.; Beex, L.V. 1993: Tumor markers in screening, diagnosis and treatment of patients with breast carcinoma Nederlands Tijdschrift Voor Geneeskunde 137(46): 2354-2357
Gusak, V.V.; Alekseenko, A.V.; Seniutovich, R.V. 1994: Use of transcutaneous electrophoresis of thiophosphamide in multimodal treatment of malignant tumor of the breast Klinicheskaia Khirurgiia 7: 64
Saccomandi, E.; Clough, K.B.; Mosseri, V.; Viehl, P.; Legal, M.; Fourquet, A.; Renolleau, C.; Durand, J.C. 1995: Breast cancer without palpable tumor revealed by microcalcifications. Prognosis and treatment Presse Medicale 24(28): 1291-1295
Veronesi, U.; Costa, A.; Grandi, C. 1977: Extent of surgical treatment of breast cancer depending on the spread of the tumor process Voprosy Onkologii 23(12): 20-25
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Schuurman, J.J.; Bong, S.B.; Einarsson, R. 1996: Determination of serum tumor markers TPS and CA 15-3 during monitoring of treatment in metastatic breast cancer patients Anticancer Research 16(4b): 2169-2172
Friedrich, M. 2000: Vitamin D and breast cancer: new approaches for hormonal therapy of breast cancer Clinical and Experimental Obstetrics and Gynecology 27(2): 77-82
Kos, T.; Aksoy, S.; Sendur, M.A.N.; Arik, Z.; Civelek, B.; Kandemir, N.; Ozdemir, N.Y.; Zengin, N.; Altundag, K. 2013: Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes Journal of BUON: Official Journal of the Balkan Union of Oncology 18(3): 608-613
Stierli, P.; Spichtig, S.; Aeberhard, P. 1992: Breast saving therapy of breast cancer: sensitivity of mammography in relation to primary tumor size Helvetica Chirurgica Acta 59(1): 247-252
Medina, D.; Faulkin, L.J.; DeOme, K.B. 1970: Combined effects of 3-methylcholanthrene, mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation on the tumor-producing capabilities of the nodule outgrowth line D1 Journal of the National Cancer Institute 44(1): 159-165
Kobayashi, K.; Murakami, A.; Komatsu, S.; Nishiyama, K.; Yamashita, M.; Sugimori, W.; Kamei, Y.; Asai, H.; Ogimoto, A.; Honda, K.; Takada, Y. 2017: A Case of Stage IV Breast Cancer with Long-Term Survival by Chemotherapy Developing Pulmonary Tumor Thrombotic Microangiopathy during the Treatment Course Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(3): 243-246